Use Of Iron(III) Complex Compounds

Abstract

The present invention relates to novel therapeutic uses of iron(III) complex compounds with carbohydrates or derivatives thereof, in the preparation of a medicament for improving immune defense and/or brain performance.

1 - 12 . (canceled) 
     
     
         13 . A method of increasing brain performance in a human patient, the method consisting of administering to a human patient not having iron deficiency anemia or iron deficiency a medication consisting of an iron (III) compound selected from the group consisting of iron (III) polymaltose and an iron (III) maltodextrin complex, the iron (III) maltodextrin complex comprising a complex of an oxidation product of one or more maltodextrins with iron (III), relative to a human patient not so administered. 
     
     
         14 . A method of improving brain performance in a human patient consisting of administering to a human patient not having an iron deficiency anemia or an iron deficiency a medication consisting of an iron (III) compound selected from the group consisting of iron (III) polymaltose and an iron (III) maltodextrin complex, the iron (III) maltodextrin complex comprising a complex of an oxidation product of one or more maltodextrins with iron (III), wherein the human patient may be of any age. 
     
     
         15 . The method of  claim 13 , wherein the iron (III) polymaltose complex has a molecular weight (M w ,) of 20,000 to 500,000 Daltons. 
     
     
         16 . The method of  claim 13 , wherein the iron (III) polymaltose complex has a molecular weight (M w ) of 30,000 to 80,000 Daltons. 
     
     
         17 . The method of  claim 14 , wherein the iron (III) polymaltose complex has a molecular weight (M w ) of 20,000 to 500,000 Daltons. 
     
     
         18 . The method of  claim 14 , wherein the iron (III) polymaltose complex has a molecular weight (M w ) of 30,000 to 80,000 Daltons.